Skip to content

Bausch + Lomb BLCO Surgical — Total revenues

Other segment segments

Vision Care
$711M+8.4%
Pharmaceuticals
$266M+19.8%

Similar metrics at other companies

TFX
TFXSurgical — Net revenues
$106.79M+12.4%
Johnson & Johnson logo
JNJSURGICAL — Sales to customers (Note 9)
$396M+9.7%
Medline, Inc.
 logo
MDLNSurgical Solutions — Net Sales
$1.55B+7.4%
The Cooper Companies, Inc. logo
COOOffice and surgical — Net Sales
$214.2M+4.1%
Intuitive Surgical logo
ISRGProduct — Total Revenue
$2.34B+23.6%
Intuitive Surgical logo
ISRGInstruments and accessories — Total Revenue
$1.69B+23.3%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's surgical — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's surgical — total revenues?
Bausch + Lomb (BLCO) reported surgical — total revenues of $228M in Q1 2026.
How has Bausch + Lomb's surgical — total revenues changed year-over-year?
Bausch + Lomb's surgical — total revenues increased by 6.5% year-over-year, from $214M to $228M.
What is the long-term trend for Bausch + Lomb's surgical — total revenues?
Over 4 years (2021 to 2025), Bausch + Lomb's surgical — total revenues has grown at a 5.6% compound annual growth rate (CAGR), from $718M to $894M.
What does surgical — total revenues mean?
The total gross income generated from the sale of surgical products, including intraocular lenses and specialized surgical equipment. This is the primary measure of the surgical segment's market demand and top-line performance. Growth in this metric indicates successful product adoption and market penetration within the ophthalmic surgical space.